Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 16 studies | 74% ± 19% | |
| glutamatergic neuron | 13 studies | 79% ± 18% | |
| GABAergic neuron | 11 studies | 75% ± 20% | |
| endothelial cell | 11 studies | 35% ± 20% | |
| oligodendrocyte | 8 studies | 28% ± 19% | |
| interneuron | 7 studies | 67% ± 28% | |
| microglial cell | 7 studies | 32% ± 19% | |
| retinal ganglion cell | 7 studies | 76% ± 28% | |
| cardiac muscle cell | 7 studies | 78% ± 26% | |
| retinal cone cell | 6 studies | 30% ± 7% | |
| astrocyte | 6 studies | 32% ± 22% | |
| neuron | 5 studies | 45% ± 18% | |
| retinal bipolar neuron | 5 studies | 50% ± 17% | |
| OFF-bipolar cell | 5 studies | 55% ± 27% | |
| retina horizontal cell | 5 studies | 41% ± 19% | |
| granule cell | 4 studies | 70% ± 12% | |
| amacrine cell | 4 studies | 33% ± 5% | |
| ON-bipolar cell | 4 studies | 56% ± 28% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 61% ± 11% | |
| GABAergic interneuron | 3 studies | 86% ± 10% | |
| Purkinje cell | 3 studies | 64% ± 27% | |
| GABAergic amacrine cell | 3 studies | 47% ± 14% | |
| glycinergic amacrine cell | 3 studies | 35% ± 8% | |
| rod bipolar cell | 3 studies | 83% ± 19% | |
| adipocyte | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 3050.08 | 2520 / 2642 | 98% | 27.33 | 694 / 705 |
| adrenal gland | 100% | 5224.24 | 258 / 258 | 77% | 11.74 | 176 / 230 |
| heart | 97% | 6602.14 | 835 / 861 | 0% | 0 | 0 / 0 |
| spleen | 97% | 875.52 | 233 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 48% | 436.91 | 689 / 1445 | 46% | 1.93 | 84 / 183 |
| ovary | 7% | 33.74 | 13 / 180 | 76% | 3.09 | 325 / 430 |
| kidney | 7% | 26.66 | 6 / 89 | 67% | 2.50 | 602 / 901 |
| prostate | 10% | 58.68 | 25 / 245 | 61% | 3.34 | 307 / 502 |
| pancreas | 26% | 121.80 | 85 / 328 | 40% | 1.23 | 72 / 178 |
| thymus | 10% | 46.15 | 65 / 653 | 54% | 2.34 | 326 / 605 |
| breast | 19% | 96.36 | 85 / 459 | 45% | 2.55 | 502 / 1118 |
| lung | 7% | 47.67 | 43 / 578 | 45% | 3.03 | 515 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 38% | 1.96 | 190 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 1.30 | 16 / 45 |
| liver | 2% | 16.07 | 5 / 226 | 33% | 2.07 | 135 / 406 |
| uterus | 1% | 4.98 | 2 / 170 | 30% | 1.11 | 138 / 459 |
| adipose | 29% | 160.39 | 354 / 1204 | 0% | 0 | 0 / 0 |
| skin | 0% | 0.47 | 2 / 1809 | 21% | 0.85 | 100 / 472 |
| intestine | 7% | 34.61 | 72 / 966 | 9% | 0.23 | 50 / 527 |
| stomach | 0% | 1.00 | 1 / 359 | 13% | 0.34 | 36 / 286 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.37 | 7 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.12 | 2 / 29 |
| blood vessel | 2% | 22.74 | 28 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2000649 | Biological process | regulation of sodium ion transmembrane transporter activity |
| GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
| GO_0007507 | Biological process | heart development |
| GO_0007165 | Biological process | signal transduction |
| GO_0008344 | Biological process | adult locomotory behavior |
| GO_0050905 | Biological process | neuromuscular process |
| GO_0098908 | Biological process | regulation of neuronal action potential |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0010765 | Biological process | positive regulation of sodium ion transport |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_1905150 | Biological process | regulation of voltage-gated sodium channel activity |
| GO_1902305 | Biological process | regulation of sodium ion transmembrane transport |
| GO_0007399 | Biological process | nervous system development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0045202 | Cellular component | synapse |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| GO_0017080 | Molecular function | sodium channel regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FGF12 |
| Protein name | Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor) Fibroblast growth factor (FGF) |
| Synonyms | FGF12B FHF1 |
| Description | FUNCTION: Involved in nervous system development and function. Involved in the positive regulation of voltage-gated sodium channel activity. Promotes neuronal excitability by elevating the voltage dependence of neuronal sodium channel SCN8A fast inactivation. . |
| Accessions | ENST00000684728.1 ENST00000445105.7 [P61328-2] C9JIN3 ENST00000430714.5 A0A804HIN2 P61328 C9JUK8 Q99517 ENST00000684282.1 ENST00000450716.5 [P61328-2] C9JEN8 ENST00000683451.2 [P61328-2] ENST00000454309.7 [P61328-1] ENST00000683935.1 [P61328-2] ENST00000418610.1 ENST00000448795.5 |